Patent holdings for IPC class C07D 277/60

Total number of patents in this class: 195

10-year publication summary

18
13
21
14
11
9
10
7
9
0
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
EyePoint Pharmaceuticals, Inc.
98
11
Piramal Enterprises Limited
157
9
LG Chem, Ltd.
17639
6
Boehringer Ingelheim International GmbH
4754
6
Ligand Pharmaceuticals Incorporated
120
6
Shanghai Institute of Materia Medica, Chinese Academy of Sciences
806
6
Bristol-myers Squibb Company
4863
5
Takeda Pharmaceutical Company Limited
2943
5
Duke University
3011
4
Chaperone Therapeutics, Inc
6
4
PGI Drug Discovery LLC
27
4
Rohm and Haas Electronic Materials Korea Ltd.
330
4
Sunovion Pharmaceuticals Inc.
290
4
Idorsia Pharmaceuticals Ltd.
363
4
The Regents of the University of California
19517
3
Merck Sharp & Dohme Corp.
2219
3
CHDI Foundation, Inc.
108
3
Connexios Life Sciences Pvt. Ltd.
13
3
Masarykova Univerzita
71
3
Motac Neuroscience Limited
5
3
Other owners 99